Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis

Add-on sotatercept was previously shown to be effective in treating patients with long-standing pulmonary arterial hypertension, but its efficacy when given within 1 year after diagnosis is uncertain. New research findings are summarized in a short video.